JP2017527304A5 - - Google Patents

Download PDF

Info

Publication number
JP2017527304A5
JP2017527304A5 JP2017523184A JP2017523184A JP2017527304A5 JP 2017527304 A5 JP2017527304 A5 JP 2017527304A5 JP 2017523184 A JP2017523184 A JP 2017523184A JP 2017523184 A JP2017523184 A JP 2017523184A JP 2017527304 A5 JP2017527304 A5 JP 2017527304A5
Authority
JP
Japan
Prior art keywords
genes
subject
lung cancer
identified
clusters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017523184A
Other languages
English (en)
Japanese (ja)
Other versions
JP6775499B2 (ja
JP2017527304A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/040437 external-priority patent/WO2016011068A1/en
Publication of JP2017527304A publication Critical patent/JP2017527304A/ja
Publication of JP2017527304A5 publication Critical patent/JP2017527304A5/ja
Application granted granted Critical
Publication of JP6775499B2 publication Critical patent/JP6775499B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017523184A 2014-07-14 2015-07-14 肺がん状態の評価方法 Active JP6775499B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462024456P 2014-07-14 2014-07-14
US62/024,456 2014-07-14
US201562160403P 2015-05-12 2015-05-12
US62/160,403 2015-05-12
PCT/US2015/040437 WO2016011068A1 (en) 2014-07-14 2015-07-14 Methods for evaluating lung cancer status

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020126239A Division JP2020182489A (ja) 2014-07-14 2020-07-27 肺がん状態の評価方法

Publications (3)

Publication Number Publication Date
JP2017527304A JP2017527304A (ja) 2017-09-21
JP2017527304A5 true JP2017527304A5 (enExample) 2018-08-30
JP6775499B2 JP6775499B2 (ja) 2020-10-28

Family

ID=55078998

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017523184A Active JP6775499B2 (ja) 2014-07-14 2015-07-14 肺がん状態の評価方法
JP2020126239A Pending JP2020182489A (ja) 2014-07-14 2020-07-27 肺がん状態の評価方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020126239A Pending JP2020182489A (ja) 2014-07-14 2020-07-27 肺がん状態の評価方法

Country Status (8)

Country Link
US (2) US20160130656A1 (enExample)
EP (2) EP3916110A1 (enExample)
JP (2) JP6775499B2 (enExample)
KR (1) KR102461014B1 (enExample)
CN (2) CN114807368A (enExample)
AU (2) AU2015289758B2 (enExample)
CA (1) CA2954169A1 (enExample)
WO (1) WO2016011068A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2360278A1 (en) 2005-04-14 2011-08-24 Trustees Of Boston University Diagnostic for lung disorders using class prediction
EP1999472A2 (en) 2006-03-09 2008-12-10 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
AU2008302076B2 (en) 2007-09-19 2015-06-11 The Trustees Of Boston University Identification of novel pathways for drug development for lung disease
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
WO2014186036A1 (en) 2013-03-14 2014-11-20 Allegro Diagnostics Corp. Methods for evaluating copd status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
EP4180531A3 (en) 2016-05-12 2023-08-23 Trustees of Boston University Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
CN109715830A (zh) * 2016-06-21 2019-05-03 威斯塔解剖学和生物学研究所 用于使用基因表达谱诊断肺癌的组合物和方法
WO2018009915A1 (en) 2016-07-08 2018-01-11 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
EP3513344A1 (en) * 2016-09-14 2019-07-24 Philip Morris Products S.a.s. Systems, methods, and gene signatures for predicting a biological status of an individual
US11244764B2 (en) 2016-12-21 2022-02-08 Cerner Innovation, Inc. Monitoring predictive models
US11408887B2 (en) 2017-05-22 2022-08-09 The National Institute for Biotechnology in the Negev Ltd. Biomarkers for diagnosis of lung cancer
JP2020522690A (ja) * 2017-06-02 2020-07-30 ベラサイト インコーポレイテッド 肺疾病の特定又はモニタリング方法及びシステム
CA3085464A1 (en) 2017-12-19 2019-06-27 The Wistar Institute Of Anatomy And Biology Compositions and methods for diagnosing lung cancers using gene expression profiles
EP3817650A4 (en) * 2018-07-02 2022-04-13 3M Innovative Properties Company Sensing system and method for monitoring time-dependent processes
KR102274564B1 (ko) * 2018-07-03 2021-07-07 (주) 프로큐라티오 빅데이터분석기반 암진단장치
CN108998531B (zh) * 2018-08-31 2021-10-01 昆明医科大学第一附属医院 肺癌下调长链非编码rna标志物及其应用
CN109615075B (zh) * 2018-12-14 2022-08-19 大连海事大学 一种基于多层聚类模型的居民日常行为识别方法
US20210287795A1 (en) * 2020-03-12 2021-09-16 Optellum Limited Cad device and method for assisting an estimation of lung disease from medical images
CN113801936B (zh) * 2020-03-30 2022-04-19 中国医学科学院肿瘤医院 用于肺癌诊断的试剂盒、装置及方法
CN114317745B (zh) * 2020-03-30 2022-06-07 中国医学科学院肿瘤医院 外泌体arpc5、eri3等在肺癌诊断中的应用
CN111863130A (zh) * 2020-04-07 2020-10-30 至本医疗科技(上海)有限公司 肿瘤免疫治疗预后标志物的筛选方法及应用
CN112034185A (zh) * 2020-09-11 2020-12-04 上海市胸科医院 Gpr110、vegfr、cd34在鉴别肺腺癌亚型中的用途
WO2022212283A1 (en) * 2021-03-29 2022-10-06 Veracyte, Inc. Methods and systems to identify a lung disorder
US12094107B2 (en) * 2021-04-07 2024-09-17 Optellum Limited CAD device and method for analyzing medical images
CN113444796B (zh) * 2021-06-29 2023-02-07 浙江医院 与肺癌相关的生物标志物及其在诊断癌症中的应用
KR102417602B1 (ko) * 2021-11-30 2022-07-07 (주)플라스바이오 인공 지능 모델 기반 종양 관리 장치 및 방법
CN114854755B (zh) * 2022-05-30 2023-05-23 陕西师范大学 一种抑制vstm2l表达的慢病毒载体及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097666A2 (en) 2002-05-16 2003-11-27 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening
EP1633892A4 (en) 2003-06-10 2007-10-24 Univ Boston DETECTION METHODS FOR LUNG DISEASES
EP1692255A4 (en) 2003-11-12 2010-12-08 Univ Boston EXTRACTION OF NUCLEIC ACID FROM EPITHELIAL CELLS FROM THE MOUTH
EP2360278A1 (en) 2005-04-14 2011-08-24 Trustees Of Boston University Diagnostic for lung disorders using class prediction
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
EP1999472A2 (en) 2006-03-09 2008-12-10 The Trustees Of Boston University Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
WO2007142936A2 (en) * 2006-05-30 2007-12-13 Duke University Prediction of lung cancer tumor recurrence
KR101443214B1 (ko) * 2007-01-09 2014-09-24 삼성전자주식회사 폐암 환자 또는 폐암 치료를 받은 폐암 환자의 폐암 재발 위험을 진단하기 위한 조성물, 키트 및 마이크로어레이
WO2008140774A2 (en) 2007-05-08 2008-11-20 Picobella Llc Methods for diagnosing and treating prostate and lung cancer
AU2008302076B2 (en) 2007-09-19 2015-06-11 The Trustees Of Boston University Identification of novel pathways for drug development for lung disease
US20100055689A1 (en) 2008-03-28 2010-03-04 Avrum Spira Multifactorial methods for detecting lung disorders
GB0811413D0 (en) * 2008-06-20 2008-07-30 Kanton Basel Stadt Gene expression signatures for lung cancers
MX2012014268A (es) * 2010-07-09 2013-02-12 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
KR20130017525A (ko) 2011-08-11 2013-02-20 주식회사 젠닥스 대장암, 유방암, 신장암 또는 갑상선암의 조기 진단을 위한 바이오 마커 및 이의 용도
CA2846837A1 (en) * 2011-08-29 2013-03-07 Cardiodx, Inc. Methods and compositions for determining smoking status
US9753043B2 (en) * 2011-12-18 2017-09-05 20/20 Genesystems, Inc. Methods and algorithms for aiding in the detection of cancer
US20150088430A1 (en) * 2012-04-26 2015-03-26 Allegro Diagnostics Corp Methods for evaluating lung cancer status
US20140220006A1 (en) * 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers

Similar Documents

Publication Publication Date Title
US20250297325A1 (en) Source of origin deconvolution based on methylation fragments in cell-free dna samples
US12462896B2 (en) Method and system for predicting response to immune anticancer drugs
JP2014521926A5 (enExample)
WO2019153595A1 (zh) 慢阻肺发病风险预测方法、服务器及计算机可读存储介质
WO2016094330A3 (en) Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP2016517291A5 (enExample)
JP2009535644A5 (enExample)
EP3899952A1 (en) Anomalous fragment detection and classification
JP2009516501A5 (enExample)
JP2013520960A5 (enExample)
CN106295241A (zh) 基于brca1和brca2突变的乳腺癌患病风险评估算法
EA201400131A1 (ru) Новый классификатор для молекулярной классификации миеломной болезни
CN105095595A (zh) 基于种群聚集程度的粒子群算法
JP2016515390A5 (enExample)
Yu et al. Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma
CN105654174B (zh) 用于预测的系统和方法
CN102419791A (zh) 人类常见病遗传风险评估方法
Wang et al. Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis
Yan et al. Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery
Gradin et al. Batch adjustment by reference alignment (BARA): Improved prediction performance in biological test sets with batch effects
CN116959719A (zh) 一种数据处理方法及非小细胞肺癌脑转移风险预测系统
JP2014501496A5 (enExample)
Singer et al. Comment on Adamzik et al.: An increased alveolar CD4+ CD25+ Foxp3+ T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality
Wirtz et al. Single-cell RNA sequencing of peripheral blood mononuclear cells in patients with acutely decompensated cirrhosis reveals a specific monocyte subset associated with an increased risk of progression to ACLF
Tan et al. Classification of colon cancer based on the expression of randomly selected genes